1 completed, 1 recruiting. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 1, Recruiting 1 |
Follow Pediatric ulcerative colitis: new trials by email Literature Review of Pediatric ulcerative colitis trials Research Report on Pediatric ulcerative colitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON) Mirikizumab - Ulcerative Colitis, Ulcerative Colitis Chronic | Phase 3 | Recruiting | Eli Lilly and Company | 150 | 2021-05-26 | 2026-10-07 |
| Clinical Study of TA-650 in Pediatric Patients With Ulcerative Colitis TA-650 - Pediatric Ulcerative Colitis | Phase 3 | Completed | Tanabe Pharma Corporation | 21 | 2012-02-01 | 2026-01-07 |
Colitis, Ulcerative (1) · Crohn Disease (1) · Inflammatory Bowel Diseases (1) · Pediatric Crohn's disease (1)
Colitis (1) · Colonic Diseases (1) · Digestive System Diseases (1) · Gastroenteritis (1) · Gastrointestinal Diseases (1) · Intestinal Diseases (1)
mirikizumab (1)
Eli Lilly and Company (1) · Tanabe Pharma Corporation (1)
Japan (2) · Austria (1) · Belgium (1) · Brazil (1) · Canada (1) · Germany (1) · Israel (1) · Italy (1) · Netherlands (1) · Norway (1) · Poland (1) · Portugal (1) · South Korea (1) · Spain (1) · United Kingdom (1)
Kazuoki Kondo, MD (1) · Toshifumi Hibi, MD (1)